Enhanced expression of fas-associated death domain-like IL-1-converting enzyme (FLICE)-inhibitory protein induces resistance to fas-mediated apoptosis in activated mast cells

Journal of Immunology

Volumn 165, Issue 11, 2000, Pages 6262-6269

  Yoshikawa, H ^a   Nakajima, Y ^a   Tasaka, K ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; FAS ANTIGEN; INTERLEUKIN 1; NERVE GROWTH FACTOR;

ALLERGIC REACTION; ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL DEATH; CROSS LINKING; ENZYME ACTIVITY; ENZYME INHIBITION; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN SYNTHESIS INHIBITION;

EID: 0034544565     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.11.6262     Document Type: Article

References (56)

1. The two faces of the mast cell
2. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α
3. Critical protective role of mast cells in a model of acute septic peritonitis
4. + bone marrow progenitor cells
5. FcγRIII-mediated regulation of hematopoiesis in murine bone marrow cells by interleukin-3 and CD95 (Fas/Apo-1)
6. + pluripotent progenitor cells
7. Differential regulation of mast cell function by IL-10 and stem cell factor
8. Glucocorticoid suppresses autocrine survival of mast cells by inhibiting IL-4 production and ICAM-1 expression
9. IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3: Prevention of apoptosis by c-kit ligand
10. Costimulation of fibronectin receptor promotes FcγR-mediated rescue of IL-3-dependent bone marrow-derived cells from apoptosis
11. Glucocorticoids decrease tissue mast ceil number by reducing the production of the c-kit ligand, stem cell factor, by resident cells
12. Role of kit-ligand in proliferation and suppression of apoptosis in mast cells: Basis for radiosensitivity of white spotting and steel mutant mice
13. Fas (CD95, Apo-1) antigen expression and function in murine mast cells
14. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen
15. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils
16. Fas ligation triggers apoptosis in macrophages but not endothelial cells
17. Differential regulation of CD95 (Fas/APO-1) expression in human blood eosinophils
18. The role of APO-I-mediated apoptosis in the immune system
19. The role of caspases in development, immunity, and apoptotic signal transduction: Lessons from knockout mice
20. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked
21. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis
22. Bcl-x protects primary B cells against Fas-mediated apoptosis
23. 1-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD95-induced apoptosis
24. Inhibition of death receptor signals by cellular FLIP
25. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases
26. A single BIR domain of XIAP sufficient for inhibiting caspases
27. Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, Sentrin
28. Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells
29. A novel gene coding for a Fas apoptosis inhibitory molecule (FAIM) isolated from inducibly Fas-resistant B lymphocytes
30. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1, 1991
31. Pro-caspase-3 is a major physiologic target of caspase-8
32. Lack of release of cytochrome c from mitochondria into cytosol early in the course of Fas-mediated apoptosis of Jurkat cells
33. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis
34. Two CD95 (APO-1/Fas) signaling pathways
35. Differential modulation of apoptosis sensitivity in CD95 type I and type II cells
36. Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria
37. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while Bcl-x(L) prevents this release but not tumor necrosis factor-RI/Fas death
38. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-1-3 not BCL-X
39. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis
40. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC
41. FLIP prevents apoptosis induced by death receptors but not by perforin/granzyme B, chemotherapeutic drugs, and gamma irradiation
42. The IL-1β-converting enzyme (caspase-I) inhibits apoptosis of inflammatory neutrophils through activation of IL-1β
43. Mcl-1 expression in human neutrophils: Regulation by cytokines and correlation with cell survival
44. Inhibition of Fas death signals by FLIPs
45. Primed T cells are more resistant to Fas-mediated activation-induced cell death than naive T cells
46. The role of c-FLIP in modulation of CD95-induced apoptosis
47. The role of interleukin-2 in regulating the sensitivity of natural killer cells for Fas-mediated apoptosis
48. FLICE-inhibitory protein expression during macrophage differentiation confers resistance to Fas-mediated apoptosis
49. Inhibition of Fas-mediated apoptosis by the B cell antigen receptor through c-FLIP
50. Biochemical mechanisms of IL-2-regulated Fas- mediated T cell apoptosis
51. Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis
52. TCR engagement regulates differential responsiveness of human memory T cells to Fas (CD95)-mediated apoptosis
53. Mitogen-activated protein kinase antagonized Fas-associated death domain protein-mediated apoptosis by induced FLICE-inhibitory protein expression
54. Fas ligand (FasL, CD95L, APO-IL) expression in murine mast cells
55. Delayed eosinophil programmed cell death in vitro: A common feature of inhalant allergy and extrinsic and intrinsic atopic dermatitis
56. Significant delay of apoptosis and Fas resistance in eosinophils of subjects with intrinsic and extrinsic type of atopic dermatitis